rAHF-PFM

recombinant protein-free manufactured factor VIII · Baxalta (now part of Shire)

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for rAHF-PFM, covering 2011-07-15 to 2021-05-05. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Pediatric Patients in Canada With Hemophilia A - A Continuation of Baxter Study 060101 [Phase 2, Phase 3]

See pricing